Abstract
The compound coded B-19036, an octadentate chelate of the paramagnetic ion Gd3+ (3, 6 ,9-triaza-12-oxa-3, 6, 9-tricarboxymethylene -10-carboxy-13-phenyl-tridecanoic acid, gadolinium chelate, Fig. 1), is a new contrast agent for magnetic resonance imaging, developed in our laboratories (Felder et al. 1985). Systemic and neural tolerance for B-19036 was evaluated both after intravenous and intrathecal administration.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Corsico N, Tirone P (1987) EEG studies in the conscious unrestrained rat: a tool for the study of immediate and delayed neurotoxicity of contrasts media. In: Calabrò A, Leonardi M (eds) Computer Aided Neuroradiology p 255–258
Felder E et al. (1985) Bracco Industria Chimica EP Patent application n. 230893
Irwin S (1968) Comprehensive observational assessement: Ia-A systematic quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia 13, 222–236
Litchfield Jr J T, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Therap 96, 99–113
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Corsico, N., Tirone, P. (1989). Neurophysiologic Assessment of Neural Tolerance of a New Paramagnetic Complex. In: Nadjmi, M. (eds) Imaging of Brain Metabolism Spine and Cord Interventional Neuroradiology Free Communications. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74337-5_167
Download citation
DOI: https://doi.org/10.1007/978-3-642-74337-5_167
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-74339-9
Online ISBN: 978-3-642-74337-5
eBook Packages: Springer Book Archive